BioSpace News Archive

Clinical Genomics (“CG” or the “Company”), a provider of colorectal cancer diagnostic solutions, including liquid biopsy tests, today announced that Betsy Hanna, Chief Executive Officer, will present at the 2020 Canaccord Genuity Virtual Medical Technologies & Diagnostics Forum as follows: Date: Thursday, November 19, 2020 Time: 11:00 a.m. Eastern Time Webcast: https://www.meetmax.com/sched/event_67247/entity_login.html?att

Avinger, Inc. today reported results for the third quarter ended September 30, 2020.

Recently completed acquisition of Viridian Therapeutics, including an anti-IGF-1R monoclonal antibody, VRDN-001, for the potential treatment of thyroid eye disease (TED) Private placement financing proceeds of approximately $91 million positions miRagen to potentially advance multiple compounds through Phase 2 proof of concept studies in TED and expand its orphan disease pipeline

Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) today published its 2020 Sustainability Report, highlighting key environmental, social and governance developments at the Company and announcing new diversity and environmental goals.

CONMED Corporation (NYSE: CNMD) today announced that its presentation time at the Jefferies Virtual London Healthcare Conference has been changed to 11:25 a.m. ET on Wednesday, November 18, 2020. Representing the Company will be Todd W. Garner, Executive Vice President and Chief Financial Officer. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.con

Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today provided a business update and reported financial results for the third quarter of 2020. “We are very pleased to reach the significant milestone

Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer is scheduled to present at the Jefferies Virtual London Healthcare Conference. Details of the presentation are as follows: Event: Jefferies Virtual London Healthcare Conference Format: Fireside Chat and 1x1 Meetings Fireside Chat Date: Tuesday, November 17, 2020 Firesi

Keiretsu Forum announced today that OtoNexus Medical Technologies was named ‘Most Valued Company’ at the virtual Keiretsu Forum Investor Capital Expo. Keiretsu Forum is the world’s largest angel investor n

Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that company management will present at the Jefferies Virtual London Healthcare Conference on Tuesday November 17, 2020 at 12:35pm ET. A live webcast of the presentation can be a

The stakes have never been higher for the millions of Californians who rely on the Affordable Care Act for access to the vital health care services they and their loved ones count on every day.